⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

BBIO

BridgeBio Pharma, Inc.

Healthcare · Biotechnology

68.56USD

+0.4400 (+0.65%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on BBIO.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 68.56
P/E—
Dvd Ind Yld0.0%
P/B—
P/S18.8
Curr EV/T12M EBITDA-34.0
Mkt Cap (USD)13.4B
Curr EV (USD)16.1B
2)

Per Share Data

EPS T12M-3.59
DPS0.01
Bk Val Per Sh-12.88
Rev/Sh3.64
Cash/Sh3.68
Curr Shares Out195.5M
FCF/Sh-2.22
3)

Cash Flow Analysis

P/CF-30.9
Curr P/FCF-30.8
CF/NI0.6
Dvd P/O-0.1%
Cash Gen/Cash Reqd-215.9
Csh Dvd Cov-435.7
CFO/Sales-60.9%
Eff Interest Rate3.7%
4)

Growth Potential

Dil EPS 1Y Gr-31.3%
Cap 1Y Gr92.3%
BPS 1Y Gr-38.1%
R&D To Sales70.9%
Retention Rate100.1%
Rev 1Y Gr126.3%
FCF 1Y Gr14.3%
Assets 1Y Gr1.8%
5)

Profitability

EBITDA-0.5B
EBIT-0.5B
Operating Margin-69.8%
Pretax Margin-100.8%
Net Margin-98.5%
ROA-61.1%
ROE32.6%
ROC—
Asset Turnover0.62
6)

Structure

Current Ratio1.23
Quick Ratio1.09
Debt/Assets218.2%
Debt/Com Eq-105.6%
Net Debt/EBITDA-4.02
Tot Debt/Capital1880.0%
Gross Margin94.4%
EBIT/Int Exp-10.0

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.